Volume 28, Issue 4 (Avicenna Journal of Clinical Medicine-Winter 2022)
Avicenna J Clin Med 2022, 28(4): 222-216 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Bazzazi N, Salehi H, Seif Rabiei M A, Mazdeh M. Evaluation of Visual Signs and Symptoms in Patients with Alzheimer's Disease. Avicenna J Clin Med 2022; 28 (4) :222-216
URL: http://sjh.umsha.ac.ir/article-1-2281-en.html
URL: http://sjh.umsha.ac.ir/article-1-2281-en.html
1- Associate Professor, Department of Ophthalmology, School of Medicine, Hamadan University of Medical Sciences
2- General Practitioner, Hamadan University of Medical Sciences, Hamadan, Iran
3- Associate Professor, Department of Social Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
4- Professor, Department of Neurology, Hamadan University of Medical Sciences, Hamadan, Iran , mehrdokhtmazdeh@yahoo.com
2- General Practitioner, Hamadan University of Medical Sciences, Hamadan, Iran
3- Associate Professor, Department of Social Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
4- Professor, Department of Neurology, Hamadan University of Medical Sciences, Hamadan, Iran , mehrdokhtmazdeh@yahoo.com
Abstract: (2258 Views)
Background and Objective:Patients with Alzheimer's disease have impaired visual function even in the early stages of the disease. Therefore, the present study aimed to determine the visual signs and symptoms in patients with Alzheimer's disease and compare them with those in the control group.
Materials and Methods:This cross-sectional descriptive study was conducted on 19 Alzheimer patients and 19 cognitively healthy people referring to Farshchian Sina Hospital, Hamadan in 2020-2021. They underwent visual examinations, including visual acuity, slit lamp exam, fundoscopy,contrast sensitivity assessed by CVS-1000 test, color perception test, investigating eye movements, and pupillary light reflex. Moreover, OCT images were taken from all patients and the control group to measure macular thickness and volume. The data were analyzed in SPSS software (version 16) using X2 statistical test.
Results:A significant reduction in visual acuity (P=0.006 for the right eye and P=0.003 for left eye), contrast sensitivity (P˂ 0.001), impaired color vision (P=0.016), increased cup to disk ratio (P˂0.001 for both eyes), reduction in temporal vascular diameter of both eyes (P˂0.001), disturbed movement (P=0.001), and sluggish pupillary light reflex (P˂0.001) were observed in patients with Alzheimer disease. Moreover, a significant reduction was detected in macular thickness and volume, especially in the inferior quadrant, in patients with Alzheimer's, as compared to the healthy group (P˂0.001). Nonetheless, there was no significant difference between the two groups in the incidence of age-related macular degeneration, cataracts, and pseudoexfoliation.
Conclusion:Patients with Alzheimer's disease have abnormal results on eye examinations.
Materials and Methods:This cross-sectional descriptive study was conducted on 19 Alzheimer patients and 19 cognitively healthy people referring to Farshchian Sina Hospital, Hamadan in 2020-2021. They underwent visual examinations, including visual acuity, slit lamp exam, fundoscopy,contrast sensitivity assessed by CVS-1000 test, color perception test, investigating eye movements, and pupillary light reflex. Moreover, OCT images were taken from all patients and the control group to measure macular thickness and volume. The data were analyzed in SPSS software (version 16) using X2 statistical test.
Results:A significant reduction in visual acuity (P=0.006 for the right eye and P=0.003 for left eye), contrast sensitivity (P˂ 0.001), impaired color vision (P=0.016), increased cup to disk ratio (P˂0.001 for both eyes), reduction in temporal vascular diameter of both eyes (P˂0.001), disturbed movement (P=0.001), and sluggish pupillary light reflex (P˂0.001) were observed in patients with Alzheimer disease. Moreover, a significant reduction was detected in macular thickness and volume, especially in the inferior quadrant, in patients with Alzheimer's, as compared to the healthy group (P˂0.001). Nonetheless, there was no significant difference between the two groups in the incidence of age-related macular degeneration, cataracts, and pseudoexfoliation.
Conclusion:Patients with Alzheimer's disease have abnormal results on eye examinations.
Type of Study: Original |
Subject:
Ophthalmology (all specialties)
Extended Abstract [HTML 19 KB] (85 Download)
References
1. 2020 Alzheimer's disease facts and figures. Alzheimer's and dementia. 2020;17(3):327-406. [DOI] [PubMed]
2. Colligris P, Jesus M, Colligris B, Pintor J. Ocular manifestation of Alzheimer's and other neurodegenerative disease: the prospect of the eye as a tool for the early diagnosis of alzheimer's disease. J Ophthalmol. 2018;2018:8538573. [DOI] [PubMed]
3. Hart JN, Koronyo Y, Black KL, Kornyo-Hamaoui M. Ocular indicators of Alzheimer's: exploring disease in the retina. Acta Neurophathol. 2016;132(6):767-787. [DOI] [PubMed]
4. Rosen PN. Vision screening for Alzheimer's disease: prevention from an ophthalmologist's perspective. Perm J. 2004;8(1):15-21. [PubMed]
5. Armstrong RA. Alzheimer’s disease and the eye. J Ophthalmol. 2009;2(3):103-111
6. Tian T, Zhang B, Jia Z. Promise and challenge: the lens as a biomarker for early diagnosis of Alzheimer's disease. Dis Markers. 2014;2014:826503. PMID: 24688166 [DOI]
7. Tzekov R, Mullan M. Vision function abnormalities in Alzheimer disease. Surv Ophtalmol. 2014;59:414-433. [DOI] [PubMed]
8. Javaid FZ, Brenton J, Guo L, Cordeiro MF. Visual and ocular manifestation of Alzheimer’s disease and their use as biomarkers for diagnosis and progression. Front Neurol. 2016;7:55. [DOI] [PubMed]
9. Molitor RJ, Ko PC. Ally BA. Eye movements in Alzheimer’s disease. J Alzheimers Dis. 2015;44(1):1-12. [DOI] [PubMed]
10. Pache M, Smeets CH, Gasio PF, Savaskam E, Flammer J, Wirz-Justice A, et al. Colour vision deficiencies in Alzheimer's disease. Age Ageing. 2003 32(4):422-426. [DOI] [PubMed]
11. Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer’s disease. Neurosci lett. 2010;480(1):69-72. [DOI] [PubMed]
12. Fotiou D, Brozou C, Haidich A, Tsiptsios D, Nakou M, Kabitsi A, et al. Pupil reaction to light in Alzheimer's disease: evaluation of pupil size changes and mobility. Aging Clin Exp Res. 2007;19(5):364-371. [DOI] [PubMed]
13. Crow RW, Levin LB, La Bree L, Rubin R, Feldon SE. Sweep visual evoked potential evaluation of contrast sensitivity in Alzheimer's dementia. Invest Ophthalmol Vis Sci.2003; 44(2):875-8. [DOI] [PubMed]
14. Salobrar-Garcia E, de Hoz R, Ramirez AL, Lopez-Cuenca I, Rojas P, Vazirani R, et al. Changes in visual function and retinal structure in the progression of Alzheimer's disease. PLoS One. 2019;14(8):e0220535. [DOI] [PubMed]
15. Scinto LF, Daffner KR, Costro L, Weintraub S, Vavrik M, Mesulam M. Impairmemt of spatially directed attention in patients with probable Alzheimer's disease as measured by eye movements. Arch Neurol. 1994; 51(7):682-8. [DOI] [PubMed]
16. Smilnak GJ, Deans JR, Doraiswamy PM, Stinnett S, Whitson HE, Lad EM. Comorbidity of age related macular degeneration with Alzheimer's disease: A histopathologic case-control study. PLoS One. 2019;14(9):e0223199. [DOI] [PubMed]
17. O'Bryhim BE, Apte RS, Kung N, Coble D, Stavern G. Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 2018; 136(11):1242-1248. [DOI] [PubMed]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences
Published by UMSHA Press
Journal Tel: +988138380924
Publisher Tel:+988138380548
Website: http://sjh.umsha.ac.ir
Email: s_ journal[at]umsha.ac.ir
